Management of benign liver tumors

被引：7

作者：

Fuchs, J. ^{[1
]}

Warmann, S. W. ^{[1
]}

Urla, C. ^{[1
]}

Schaefer, J. F. ^{[2
]}

Schmidt, A. ^{[1
]}

机构：

[1] Univ Tubingen, Dept Pediat Surg & Pediat Urol, Childrens Hosp, Hoppe Seyler Str 03, D-72076 Tubingen, Germany

[2] Univ Tubingen, Dept Intervent & Diagnost Radiol, Tubingen, Germany

来源：

SEMINARS IN PEDIATRIC SURGERY | 2020年 / 29卷 / 04期

关键词：

Pediatric liver tumors; Focal nodular hyperplasia; Adenoma; Hamartoma; Hemangioma; Inflammatory myofibroblastic tumor; Liver cysts; FOCAL NODULAR HYPERPLASIA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; MESENCHYMAL HAMARTOMA; HEPATIC CYSTS; CHILDREN; DIAGNOSIS; HEMANGIOMAS; CHILDHOOD; ARCHIVES; FEATURES;

D O I：

10.1016/j.sempedsurg.2020.150941

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Benign liver tumors in children are far less frequent than their malignant counterparts. Recently, there have been advances of diagnostic procedures and novel treatments with improved classification as a result. While malignant pediatric liver tumors have been comprehensively addressed by multicenter international tumor trials, benign tumors have more usually relied upon individualised workup and treatment. Due to the rarity and heterogeneity of these different entities, lar ge studies are lacking. In this article the authors highlight the spectrum of benign liver tumors with special focus on specific clinical features, pathology, and treatment. (C) 2020 Published by Elsevier Inc.

引用

页数：9